LEROY MEDICAL : revenue, balance sheet and financial ratios

LEROY MEDICAL is a French company founded 28 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in L'HAY-LES-ROSES (94240), this company of category PME shows in 2022 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LEROY MEDICAL (SIREN 418595914)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C 1 255 759 € 1 348 759 € 1 284 189 € 1 254 031 € 1 323 869 € 1 171 911 € 1 140 759 €
Net income 3 960 € 1 625 € -4 373 € -27 735 € 32 979 € 65 125 € 9 818 € 70 484 € 32 751 € -4 764 €
EBITDA N/C N/C N/C 23 196 € 84 391 € 135 027 € 60 297 € 108 304 € 58 333 € 17 842 €
Net margin N/C N/C N/C -2.2% 2.4% 5.1% 0.8% 5.3% 2.8% -0.4%

Revenue and income statement

In 2025, LEROY MEDICAL generates positive net income of 4 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

3 960 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 62%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

62.336%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

28.901%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

10.8%

Solvency indicators evolution
LEROY MEDICAL

Sector positioning

Debt ratio
62.34 2025
2023
2024
2025
Q1: 1.7
Med: 22.17
Q3: 81.11
Average -7 pts over 3 years

In 2025, the debt ratio of LEROY MEDICAL (62.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
28.9% 2025
2023
2024
2025
Q1: 19.14%
Med: 38.79%
Q3: 62.8%
Average -8 pts over 3 years

In 2025, the financial autonomy of LEROY MEDICAL (28.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 121.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

121.641

Liquidity indicators evolution
LEROY MEDICAL

Sector positioning

Liquidity ratio
121.64 2025
2023
2024
2025
Q1: 116.06
Med: 197.47
Q3: 330.73
Average

In 2025, the liquidity ratio of LEROY MEDICAL (121.64) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LEROY MEDICAL

Positioning of LEROY MEDICAL in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Valuation estimate

Based on 69 transactions of similar company sales (all years), the value of LEROY MEDICAL is estimated at 15 916 € (range 6 228€ - 48 431€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
69 tx
6k€ 15k€ 48k€
15 916 € Range: 6 228€ - 48 431€
NAF 5 all-time

Valuation method used

Net Income Multiple
3 960 € × 4.0x = 15 917 €
Range: 6 228€ - 48 432€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare LEROY MEDICAL with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres biens personnels et domestiques

Frequently asked questions about LEROY MEDICAL

What is the revenue of LEROY MEDICAL ?

The revenue of LEROY MEDICAL in 2022 is 1.3 M€.

Is LEROY MEDICAL profitable?

Yes, LEROY MEDICAL generated a net profit of 4 k€ in 2025.

Where is the headquarters of LEROY MEDICAL ?

The headquarters of LEROY MEDICAL is located in L'HAY-LES-ROSES (94240), in the department Val-de-Marne.

Where to find the tax return of LEROY MEDICAL ?

The tax return of LEROY MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LEROY MEDICAL operate?

LEROY MEDICAL operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.